SMARCAD1 and neoplasm: If indeed conserved, then this raises the question of whether it might be possible to inhibit the growth of hamartin/tuberin deficient tumor cells by recapitulating the phenotypic effects of SMARCAD1 or PPP2R4 loss of function.